- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 14, 2025 | 100.07M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $450.48K |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $1.98M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $2.14M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $2.47M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $2.56M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $548.11K |
| Current Assets | Q2 2025 · Jun 30, 2024 | $270.02K |
| Total Assets | Q2 2025 · Dec 31, 2024 | $910.78K |
| Total Assets | Q2 2025 · Jun 30, 2024 | $873.69K |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 99.43M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 99.43M sh |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$129.42K |
| Stockholders Equity restated | Q2 2025 · Dec 31, 2023 | −$1.72M |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2023 | $1.28M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.00 |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $464.37K |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $985.28K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$220.01K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$618.61K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$197.08K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$558.09K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $448.67K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $804.94K |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $985.47K |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $1.8M |
| Revenue | Q2 2025 · Dec 31, 2023 | $1.43M |
| Revenue | Q2 2025 · Dec 31, 2023 | $2.6M |